Taken together, our results describe a new correlation between MLL2/KMT2D and MLL3/KMT2C with CML, showing that the expression of these genes clearly decreased during disease progression. Here, KMT2C is linked to chronic myelogenous leukemia, BCR-ABL1 positive.